News

Aclarion Unveils NOCISCAN Innovation at Upcoming Spine Summit

Aclarion Unveils NOCISCAN Innovation at Upcoming Spine Summit

Aclarion's Groundbreaking Technology at the Spine Summit

Aclarion, Inc. continues to make strides in healthcare technology, particularly with its innovative NOCISCAN tool aimed at transforming how chronic low back pain is treated. During the 2025 Spine Summit, this pioneering technology will take center stage, showcasing its unique integration of Magnetic Resonance Spectroscopy (MRS) and augmented intelligence. This powerful combination is set to alter traditional approaches and enhance treatment personalization for patients suffering from chronic low back pain.

Overview of NOCISCAN Technology

NOCISCAN is an advanced decision-support platform that equips medical professionals with insights into the complexities of low back pain. By leveraging proprietary algorithms alongside MRS data, NOCISCAN helps doctors discern between painful and nonpainful discs, thus streamlining the treatment process. With approximately 266 million individuals worldwide grappling with conditions linked to degenerative spine diseases, the implications of this technology are far-reaching.

Insights from Dr. Nicholas Theodore

At the Spine Summit, Dr. Nicholas Theodore, a distinguished orthopedic surgeon renowned for his expertise in neurosurgery and orthopaedic surgery, will present his findings regarding NOCISCAN’s capabilities. As a leading authority affiliated with Johns Hopkins University, Dr. Theodore's insights are integral in demonstrating how technologies like NOCISCAN can enhance surgical outcomes by revealing information that is often missed with conventional imaging techniques.

Empowering Physicians

Brent Ness, Chief Executive Officer of Aclarion, emphasizes the importance of strong advocacy from physician leaders as it relates to innovative technologies within healthcare. He states, "Disruptive technologies require strong advocacy from physician luminaries, and insights provided by Dr. Theodore and the Aclarion KOL team have been invaluable in our mission to broaden NOCISCAN's availability." This commitment to empowering healthcare providers reflects Aclarion's focus on improving patient care.

Presentation Details at the Spine Summit

Attendees eager to learn more about NOCISCAN should note the following details for the presentation:

  • TITLE: NOCISCAN, Augmented Intelligence, and Low Back Pain Decision Support
  • PRESENTER: Dr. Nicholas Theodore
  • DATE: Friday, February 21, 2025
  • TIME: 1:15 PM EST
  • LOCATION: JW Marriott Tampa Water Street

The Impact of Chronic Low Back Pain

Chronic low back pain represents a significant global healthcare challenge. By utilizing tools like NOCISCAN, healthcare providers can garner deep insights into the nuances of back pain, which is crucial in a world where such ailments are pervasive. This innovation not only holds potential for individual patient outcomes but also represents a paradigm shift in how the medical community approaches spine health.

Next Steps for Interested Professionals

Healthcare professionals who are interested in the NOCISCAN technology or wish to explore potential partnerships are encouraged to reach out directly to Aclarion. Additionally, practitioners seeking to incorporate NOCISCAN into their diagnostic practices can find more information by contacting Aclarion through their official channels for further collaboration opportunities.

Frequently Asked Questions

What is NOCISCAN?

NOCISCAN is an evidence-supported software platform designed to assist physicians in differentiating between painful and nonpainful discs using MRS data.

Who will present at the Spine Summit?

Dr. Nicholas Theodore, a recognized expert in the field, will deliver the presentation on NOCISCAN and its applications in treating low back pain.

When is the Spine Summit?

The Spine Summit will take place on February 21, 2025, where innovative technologies like NOCISCAN will be featured.

What makes NOCISCAN stand out?

NOCISCAN utilizes augmented intelligence to enhance the diagnostic process, providing deeper insights that traditional imaging may overlook.

How can I learn more about NOCISCAN?

For more information regarding NOCISCAN, interested parties can reach out to Aclarion directly via their official communication channels.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 6

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 3

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 1

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 0

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 7

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

AGNC Investment Prepares for Earnings Announcement

Updated Category News Views 42

Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...

Continue Reading
Foraco International Announces Q3 2024 Financial Results

Updated Category News Views 191

Foraco International Reports Third Quarter 2024 Results Foraco International SA (TSX:FAR), a prominent player in the global drilling industry, has just released its financial performance for the third quarter of 2024. The Company reported a total revenue of US$77.7 million, a decline from the record US$95.1 million achieved in the same quarter last year. The current...

Continue Reading
Exploring the Future of Transparent Conductive Film Displays

Updated Category News Views 115

Overview of Transparent Conductive Film Displays Transparent Conductive Film (TCF) Displays utilize a delicate, transparent conductive layer that supports touch functionality while preserving remarkable optical clarity. These films are pivotal in numerous applications, such as touchscreen displays, flexible electronics, OLEDs, and smart windows. They act as an electrode...

Continue Reading
Watsco Announces Substantial $3.00 Quarterly Dividend Payment

Updated Category News Views 175

Watsco Announces Substantial $3.00 Quarterly Dividend Payment Watsco, Inc. (NYSE: WSO) has recently declared a quarterly cash dividend of $3.00 per share on its Common and Class B common stock. The dividend is set to be paid on July 31 to shareholders recorded as of July 16. This payment underscores Watsco's long-standing commitment to returning value to its shareholders....

Continue Reading
Milliman Giving Fund Drives Clean Water Initiatives Globally

Updated Category News Views 134

Milliman Giving Fund’s Dedication to Global Health In a notable step toward enhancing global health and hygiene, Milliman, Inc., a well-respected consulting and actuarial firm, has launched a significant initiative through its Milliman Giving Fund. Recently, the organization granted a generous $750,000 to Splash International, committing this funding over the next three...

Continue Reading